Multiplexed assay technology allows for the simultaneous detection of multiple biomarkers in a single sample. This approach increases efficiency and provides a comprehensive profile of a patient's cancer. Techniques such as mass spectrometry and microarray analysis enable the quantification of numerous proteins, nucleic acids, or metabolites, offering valuable insights into cancer biology and aiding in personalized treatment strategies.
